Rosie A Harris

At Bristol

Papers

1

Total Citations

88

H-Index

1

About

Rosie A. Harris is a leading clinical researcher whose work centers on thoracic surgery, patient-reported outcomes, and evidence-based recovery assessment in lung cancer care. Her most influential contribution is the landmark VIOLET randomized controlled trial, published in 2022, which compared video-assisted thoracoscopic surgery (VATS) lobectomy to open lobectomy for early-stage lung cancer. This study, garnering 88 citations, provided rigorous evidence that VATS improves self-reported physical function and recovery, reshaping surgical practice by prioritizing patient-centered endpoints. Harris’s research bridges the gap between surgical technique and real-world patient experience, emphasizing how minimally invasive approaches reduce tissue trauma and enhance quality of life. Her work has been instrumental in guiding clinical guidelines and informing shared decision-making for lung cancer patients. With a focus on rigorous trial design and meaningful outcomes, Harris continues to influence thoracic oncology, demonstrating that how patients feel and function after surgery is as critical as traditional metrics. Her contributions have made her a respected voice in surgical recovery research and a key figure in advancing evidence-based thoracic care.

Research Focus

Key Achievements

1
H-Index
1
Papers
88
Total Citations
88
Avg Citations/Paper
🏆 Most Cited Paper
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT
88 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: At Bristol

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago